Holen Sie sich die Stockscreener-App
1.86
0.53%
-0.01
Handel nachbörslich:
1.86
Schlusskurs vom Vortag:
$1.87
Offen:
$1.88
24-Stunden-Volumen:
46,232
Relative Volume:
0.14
Marktkapitalisierung:
$6.21M
Einnahmen:
$556.00K
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-0.8692
EPS:
-2.14
Netto-Cashflow:
$-6.23M
1W Leistung:
-11.43%
1M Leistung:
-25.60%
6M Leistung:
-40.85%
1J Leistung:
-36.95%
1-Tages-Spanne:
$1.72
$1.88
1-Wochen-Bereich:
$1.72
$2.12
52-Wochen-Spanne:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Firmenname
Cyclerion Therapeutics Inc
Sektor
Branche
Telefon
617-621-7722
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie CYCN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.86 | 5.99M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-20 | Eingeleitet | Truist | Buy |
| 2021-09-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Eingeleitet | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Aktie (CYCN) Neueste Nachrichten
Live market analysis of Cyclerion Therapeutics Inc.Trade Entry Summary & Daily Growth Stock Investment Tips - newser.com
Published on: 2025-11-03 08:27:32 - newser.com
What institutional flow reveals about Cyclerion Therapeutics Inc.Entry Point & Smart Investment Allocation Insights - newser.com
Will Cyclerion Therapeutics Inc. stock maintain growth storyJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Why Cyclerion Therapeutics Inc. stock is recommended by analysts2025 Top Gainers & Weekly High Return Stock Forecasts - newser.com
Comparing Cyclerion Therapeutics Inc. in custom built stock radarsGlobal Markets & Accurate Trade Setup Notifications - newser.com
Combining machine learning predictions for Cyclerion Therapeutics Inc.Trade Entry Summary & Weekly Setup with ROI Potential - newser.com
Short interest data insights for Cyclerion Therapeutics Inc.Portfolio Risk Summary & Comprehensive Market Scan Reports - newser.com
Is Cyclerion Therapeutics Inc. stock recession proofWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Smart tools for monitoring Cyclerion Therapeutics Inc.’s price actionJuly 2025 Summary & Daily Price Action Insights - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
Is Cyclerion Therapeutics Inc. stock entering bullish territoryTrade Volume Report & Reliable Intraday Trade Alerts - newser.com
Should you hold or exit Cyclerion Therapeutics Inc. nowQuarterly Portfolio Report & Weekly Chart Analysis and Guides - newser.com
How to monitor Cyclerion Therapeutics Inc. with trend dashboardsPortfolio Risk Summary & Daily Stock Trend Watchlist - newser.com
Is Cyclerion Therapeutics Inc. stock reversal real or fake2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
How Cyclerion Therapeutics Inc. stock reacts to inflationary pressuresQuarterly Market Review & Fast Gaining Stock Reports - newser.com
What high frequency data says about Cyclerion Therapeutics Inc.Weekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
What MACD and RSI say about Cyclerion Therapeutics Inc.Quarterly Trade Summary & Capital Efficiency Focused Ideas - newser.com
Can Cyclerion Therapeutics Inc. stock deliver surprise earnings beatPortfolio Value Summary & Low Volatility Stock Suggestions - newser.com
Published on: 2025-10-30 23:30:48 - newser.com
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):